Neumentix clinical study shows sustained attention benefits

Long-term supplementation with botanical ingredient shown to improve focus

New human clinical trial data presented at the Society for Neuroscience on Wednesday 15 November shows supplementation with patented Neumentix Phenolic Complex K110-42 supports sustained attention and focus in young, healthy individuals.

The new study used CNS Vital Signs test to evaluate the effects of Neumentix supplementation on cognitive performance compared with a placebo.

The CNS test uses a series of computerised neurocognitive tests to assess brain function.

Results showed significant improvement in sustained attention after 30 days, which lasted through the 90-day study. These results indicate long-term supplementation with Neumentix can improve focus with time.

Neumentix is a water-extracted natural dietary ingredient that was selectively bred to be high in polyphenols and targeted to support cognitive and physical performance.

Previous research suggests key polyphenols in Neumentix support working memory function in the brain through at least four potential mechanisms of action.

Polyphenols in Neumentix are suggested to support cognition by reducing oxidative stress, increasing acetylcholine, supporting the growth of new neurons and protecting existing cells.

“Neumentix stands out in the growing brain health market with its sustained, non-stimulant benefits for concentration and focus with continued use,” said Kim Colletti, Global Cognition Product Manager at Kemin Human Nutrition and Health.

“Young consumers are looking for long-term cognitive enhancement that will help them stay productive without crashing.”

According to Research and Markets, the brain health supplement market is expected to reach $11.6 billion by 2024.

Featured Companies

Kemin (more information, website)